Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tehran Daru Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer established in 1961. The company specializes in the production of a wide range of generic medicines, including tablets, capsules, and oral liquids. Its product portfolio covers various therapeutic areas such as cardiovascular diseases, gastrointestinal disorders, central nervous system conditions, and infectious diseases. Tehran Daru operates modern manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. The company is a subsidiary of Tamin Pharmaceutical Investment Company (TPICO), the largest pharmaceutical holding in Iran. It is publicly traded on the Tehran Stock Exchange and plays a significant role in the domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tehran Daru Pharmaceutical Company.